BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 26327236)

  • 1. Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.
    Tweedie D; Rachmany L; Rubovitch V; Li Y; Holloway HW; Lehrmann E; Zhang Y; Becker KG; Perez E; Hoffer BJ; Pick CG; Greig NH
    Alzheimers Dement; 2016 Jan; 12(1):34-48. PubMed ID: 26327236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice.
    Tweedie D; Rachmany L; Rubovitch V; Lehrmann E; Zhang Y; Becker KG; Perez E; Miller J; Hoffer BJ; Greig NH; Pick CG
    Exp Neurol; 2013 Jan; 239():170-82. PubMed ID: 23059457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
    Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
    J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats.
    Eakin K; Li Y; Chiang YH; Hoffer BJ; Rosenheim H; Greig NH; Miller JP
    PLoS One; 2013; 8(12):e82016. PubMed ID: 24312624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 induced glucagon-like peptide-1 receptor activation reverses behavioral impairments of mild traumatic brain injury in mice.
    Rachmany L; Tweedie D; Li Y; Rubovitch V; Holloway HW; Miller J; Hoffer BJ; Greig NH; Pick CG
    Age (Dordr); 2013 Oct; 35(5):1621-36. PubMed ID: 22892942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptor agonist Exendin-4 improves neurological outcomes by attenuating TBI- induced inflammatory responses and MAPK activation in rats.
    Zhang J; Yi T; Cheng S; Zhang S
    Int Immunopharmacol; 2020 Sep; 86():106715. PubMed ID: 32570036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury.
    Bader M; Li Y; Lecca D; Rubovitch V; Tweedie D; Glotfelty E; Rachmany L; Kim HK; Choi HI; Hoffer BJ; Pick CG; Greig NH; Kim DS
    Neurobiol Dis; 2019 Apr; 124():439-453. PubMed ID: 30471415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degeneration.
    Rachmany L; Tweedie D; Rubovitch V; Li Y; Holloway HW; Kim DS; Ratliff WA; Saykally JN; Citron BA; Hoffer BJ; Greig NH; Pick CG
    Sci Rep; 2017 Jun; 7(1):3735. PubMed ID: 28623327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic traumatic encephalopathy in blast-exposed military veterans and a blast neurotrauma mouse model.
    Goldstein LE; Fisher AM; Tagge CA; Zhang XL; Velisek L; Sullivan JA; Upreti C; Kracht JM; Ericsson M; Wojnarowicz MW; Goletiani CJ; Maglakelidze GM; Casey N; Moncaster JA; Minaeva O; Moir RD; Nowinski CJ; Stern RA; Cantu RC; Geiling J; Blusztajn JK; Wolozin BL; Ikezu T; Stein TD; Budson AE; Kowall NW; Chargin D; Sharon A; Saman S; Hall GF; Moss WC; Cleveland RO; Tanzi RE; Stanton PK; McKee AC
    Sci Transl Med; 2012 May; 4(134):134ra60. PubMed ID: 22593173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Clinical Predictors of 5-Year Outcome After Concussive Blast Traumatic Brain Injury.
    Mac Donald CL; Barber J; Jordan M; Johnson AM; Dikmen S; Fann JR; Temkin N
    JAMA Neurol; 2017 Jul; 74(7):821-829. PubMed ID: 28459953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia.
    Teramoto S; Miyamoto N; Yatomi K; Tanaka Y; Oishi H; Arai H; Hattori N; Urabe T
    J Cereb Blood Flow Metab; 2011 Aug; 31(8):1696-705. PubMed ID: 21487412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astaxanthin improves cognitive performance in mice following mild traumatic brain injury.
    Ji X; Peng D; Zhang Y; Zhang J; Wang Y; Gao Y; Lu N; Tang P
    Brain Res; 2017 Mar; 1659():88-95. PubMed ID: 28048972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mild traumatic brain injury and postconcussive syndrome: a re-emergent questioning].
    Auxéméry Y
    Encephale; 2012 Sep; 38(4):329-35. PubMed ID: 22980474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4 protected against cognitive dysfunction in hyperglycemic mice receiving an intrahippocampal lipopolysaccharide injection.
    Huang HJ; Chen YH; Liang KC; Jheng YS; Jhao JJ; Su MT; Lee-Chen GJ; Hsieh-Li HM
    PLoS One; 2012; 7(7):e39656. PubMed ID: 22844396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exenatide exerts cognitive effects by modulating the BDNF-TrkB neurotrophic axis in adult mice.
    Bomba M; Granzotto A; Castelli V; Massetti N; Silvestri E; Canzoniero LMT; Cimini A; Sensi SL
    Neurobiol Aging; 2018 Apr; 64():33-43. PubMed ID: 29331730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats.
    Xie Z; Enkhjargal B; Wu L; Zhou K; Sun C; Hu X; Gospodarev V; Tang J; You C; Zhang JH
    Neuropharmacology; 2018 Jan; 128():142-151. PubMed ID: 28986282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A2A receptor deficiency alleviates blast-induced cognitive dysfunction.
    Ning YL; Yang N; Chen X; Xiong RP; Zhang XZ; Li P; Zhao Y; Chen XY; Liu P; Peng Y; Wang ZG; Chen JF; Zhou YG
    J Cereb Blood Flow Metab; 2013 Nov; 33(11):1789-98. PubMed ID: 23921902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine attenuates brain injury but increases mortality induced by high-intensity blast wave exposure.
    Ning YL; Yang N; Chen X; Tian HK; Zhao ZA; Zhang XZ; Liu D; Li P; Zhao Y; Peng Y; Wang ZG; Chen JF; Zhou YG
    Toxicol Lett; 2019 Feb; 301():90-97. PubMed ID: 30423366
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.